Layer, Chiang, et al. Genome Biology
Benitec Says USPTO Reverses Rejection of US Patent
The patent fell under USPTO scrutiny as part of patent-infringement litigation the company initiated against now-defunct expressed RNAi shop Nucleonics, and certain claims within the intellectual property were rejected by the patent office
New to GenomeWeb? Register here quickly.